News
The European Union should allow drug prices to rise to U.S. levels in order to attract investment, the bosses of two European ...
Top Swiss officials will this week test whether big commitments to the U.S. can help secure relief from import tariffs, after ...
2d
Zacks Investment Research on MSNNovartis to Report Q1 Earnings: Will Key Drugs Maintain Momentum?Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2025 results on April 29, 2025. The Zacks ...
CEOs from European drugmakers Sanofi and Novartis have inked a letter in The Financial Times urging the European Union to set ...
While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily ...
Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...
Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, ...
Swiss and French pharmaceutical companies Novartis and Sanofi argue that the EU should adjust its drug prices to better align with those in the US.
The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...
The so-called 'Most Favored Nations' rule would set drug pricing for Medicare in line with the prices paid by other nations, ...
CANTON, OHIO – The Detroit Lions will play host to the Los Angeles Chargers in the 2025 Hall of Fame Game presented by Novartis at 8 p.m. ET Thursday, July 31, in Canton as part of Enshrinement Week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results